Precise Biometrics to provide technology to Inpeco Group
Precise Biometrics announced today that it will provide its Precise Match-on-Card technology to the Inpeco Group.
The Inpeco Group offers solutions for automating, controlling and tracing all actions performed on biological samples, from collecting to storing or retrieval, to prevent errors in sample identification and assuring a correct association patient to sample through the entire sample lifecycle.
The use of Precise Biometrics’ technology will allow Inpeco Group to provide a unique link between patient ID and the in-vitro automation process it provides. The Match-on-Card function will allow patient IDs to be verified at the point when the sample is taken, which is when blood vials are labeled and registered in a database.
“We are responsible for developing ways to ensure medical acts are delivered in the right way and that they are fully monitored,” stated Andrea Pedrazzini, President of the Inpeco Group, which includes Inpeco TIH (Traceability In Healthcare), engaged in performing the Inpeco Group’s R&D activities. “Precise Biometrics’ Match-on-Card solution is a perfect product for our Group and objectives. Its unique capabilities of combining smart cards and fingerprints ensures that a patient’s data cannot be tampered with and that it’s fully secured throughout the process, from when the blood is extracted through the testing stage. We have an accurate account of the patient’s ID, associated with the sample tube itself, and at the same time the patient’s privacy is maintained.”
With Precise Match-on-Card the fingerprint template is both stored and matched on the smart card chip. The biometrics serve as PIN and password replacement, but the solution also makes use of the well-known secure environment of the chip and eliminates the database, facilitating proof of identity and making the card a truly personal token.
“Our partnership with Inpeco Group has tremendous growth potential and we’re excited about this new venture. After a successful trial, we expect to grant Inpeco three year exclusivity in the in-vitro testing automation market because we clearly see the value and expertise they provide, their great care and investment in R&D activities and their key role on the further development of automated blood test systems”, said Precise Biometrics’ CEO, Thomas Marschall.
The Inpeco Group offers solutions for automating, controlling and tracing all actions performed on biological samples, from collecting to storing or retrieval, to prevent errors in sample identification and assuring a correct association patient to sample through the entire sample lifecycle.
The use of Precise Biometrics’ technology will allow Inpeco Group to provide a unique link between patient ID and the in-vitro automation process it provides. The Match-on-Card function will allow patient IDs to be verified at the point when the sample is taken, which is when blood vials are labeled and registered in a database.
“We are responsible for developing ways to ensure medical acts are delivered in the right way and that they are fully monitored,” stated Andrea Pedrazzini, President of the Inpeco Group, which includes Inpeco TIH (Traceability In Healthcare), engaged in performing the Inpeco Group’s R&D activities. “Precise Biometrics’ Match-on-Card solution is a perfect product for our Group and objectives. Its unique capabilities of combining smart cards and fingerprints ensures that a patient’s data cannot be tampered with and that it’s fully secured throughout the process, from when the blood is extracted through the testing stage. We have an accurate account of the patient’s ID, associated with the sample tube itself, and at the same time the patient’s privacy is maintained.”
With Precise Match-on-Card the fingerprint template is both stored and matched on the smart card chip. The biometrics serve as PIN and password replacement, but the solution also makes use of the well-known secure environment of the chip and eliminates the database, facilitating proof of identity and making the card a truly personal token.
“Our partnership with Inpeco Group has tremendous growth potential and we’re excited about this new venture. After a successful trial, we expect to grant Inpeco three year exclusivity in the in-vitro testing automation market because we clearly see the value and expertise they provide, their great care and investment in R&D activities and their key role on the further development of automated blood test systems”, said Precise Biometrics’ CEO, Thomas Marschall.
Comments